Skip to main content

Current options in antifungal pharmacotherapy.

Publication ,  Journal Article
Mohr, J; Johnson, M; Cooper, T; Lewis, JS; Ostrosky-Zeichner, L
Published in: Pharmacotherapy
May 2008

Infections caused by yeasts and molds continue to be associated with high rates of morbidity and mortality in both immunocompromised and immunocompetent patients. Many antifungal drugs have been developed over the past 15 years to aid in the management of these infections. However, treatment is still not optimal, as the epidemiology of the fungal infections continues to change and the available antifungal agents have varying toxicities and drug-interaction potential. Several investigational antifungal drugs, as well as nonantifungal drugs, show promise for the management of these infections.

Duke Scholars

Published In

Pharmacotherapy

DOI

ISSN

0277-0008

Publication Date

May 2008

Volume

28

Issue

5

Start / End Page

614 / 645

Location

United States

Related Subject Headings

  • Polyenes
  • Pharmacology & Pharmacy
  • Mycoses
  • Humans
  • Echinocandins
  • Azoles
  • Antifungal Agents
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mohr, J., Johnson, M., Cooper, T., Lewis, J. S., & Ostrosky-Zeichner, L. (2008). Current options in antifungal pharmacotherapy. Pharmacotherapy, 28(5), 614–645. https://doi.org/10.1592/phco.28.5.614
Mohr, John, Melissa Johnson, Travis Cooper, James S. Lewis, and Luis Ostrosky-Zeichner. “Current options in antifungal pharmacotherapy.Pharmacotherapy 28, no. 5 (May 2008): 614–45. https://doi.org/10.1592/phco.28.5.614.
Mohr J, Johnson M, Cooper T, Lewis JS, Ostrosky-Zeichner L. Current options in antifungal pharmacotherapy. Pharmacotherapy. 2008 May;28(5):614–45.
Mohr, John, et al. “Current options in antifungal pharmacotherapy.Pharmacotherapy, vol. 28, no. 5, May 2008, pp. 614–45. Pubmed, doi:10.1592/phco.28.5.614.
Mohr J, Johnson M, Cooper T, Lewis JS, Ostrosky-Zeichner L. Current options in antifungal pharmacotherapy. Pharmacotherapy. 2008 May;28(5):614–645.

Published In

Pharmacotherapy

DOI

ISSN

0277-0008

Publication Date

May 2008

Volume

28

Issue

5

Start / End Page

614 / 645

Location

United States

Related Subject Headings

  • Polyenes
  • Pharmacology & Pharmacy
  • Mycoses
  • Humans
  • Echinocandins
  • Azoles
  • Antifungal Agents
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences